Research Output

Filter
Comment/debate
2020

Autologous stem-cell transplantation for myeloma: Here to stay?

Holstein, S. A., Feb 1 2020, In : JCO Oncology Practice. 16, 2, p. 67-68 2 p.

Research output: Contribution to journalComment/debate

The Future of Precision Oncology for the Treatment of Solid Tumors

Klute, K. A., 2020, (Accepted/In press) In : Clinical Pharmacology and Therapeutics.

Research output: Contribution to journalComment/debate

2019

Chemoimmunotherapy for localised low-risk diffuse large B-cell lymphoma

Vose, J. M., Dec 21 2019, In : The Lancet. 394, 10216, p. 2208-2209 2 p.

Research output: Contribution to journalComment/debate

Commentary on “Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma” by Giovanni Barosi and Robert Peter Gale

Holstein, S. A., Suman, V. J. & McCarthy, P. L., Feb 1 2019, In : Leukemia. 33, 2, p. 565-566 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Correction: Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in the USA (PLoS ONE (2019) 14:1 (e0209709) DOI: 10.1371/journal.pone.0209709)

Li, Y., Appius, A., Pattipaka, T., Feyereislova, A., Cassidy, A. & Ganti, A. K., Feb 2019, In : PloS one. 14, 2, e0212831.

Research output: Contribution to journalComment/debate

Open Access

Prophylaxis of central nervous system relapse in patients with lymphoma

Kallam, A., Dec 2019, In : Clinical Advances in Hematology and Oncology. 17, 12, p. 674-676 3 p.

Research output: Contribution to journalComment/debate

2018

Burkitt's lymphoma: Challenges and practical considerations for modern therapy

Gregory Bociek, R., Nov 1 2018, In : Journal of oncology practice. 14, 11, p. 679-680 2 p.

Research output: Contribution to journalComment/debate

NCCN Guidelines ® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines

Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y. J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Engstrom, P. F., Garrido-Laguna, I., Grem, J. L., Grothey, A., Hochster, H. S., Hoffe, S., Hunt, S., Kamel, A., Kirilcuk, N., Krishnamurthi, S., Messersmith, W. A. & 16 others, Meyerhardt, J., Miller, E. D., Mulcahy, M. F., Murphy, J. D., Nurkin, S., Saltz, L., Sharma, S., Shibata, D., Skibber, J. M., Sofocleous, C. T., Stoffel, E. M., Stotsky-Himelfarb, E., Willett, C. G., Wuthrick, E., Gregory, K. M. & Freedman-Cass, D. A., Apr 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 4, p. 359-369 11 p.

Research output: Contribution to journalComment/debate

133 Scopus citations

Venetoclax in chronic lymphocytic leukaemia: a possible cure?

Kallam, A. & Armitage, J. O., Sep 2018, In : The Lancet Oncology. 19, 9, p. 1143-1144 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations
2017

Anticoagulants could be a victim of enzalutamide

Gundabolu, K., Nov 2017, In : Journal of oncology practice. 13, 11, p. 730-731 2 p.

Research output: Contribution to journalComment/debate

Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA

Bennett, C. L., Sartor, O. A., Armitage, J. O. & Kantarjian, H., Jan 1 2017, In : The Lancet Oncology. 18, 1, p. 22-23 2 p.

Research output: Contribution to journalComment/debate

6 Scopus citations

Erratum: MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer (Cancer Cell (2017) 32(1) (71–87.e7) (S1535610817302544) (10.1016/j.ccell.2017.06.004))

Shukla, S. K., Purohit, V., Mehla, K., Gunda, V., Chaika, N. V., Vernucci, E., King, R. J., Abrego, J., Goode, G. D., Dasgupta, A., Illies, A. L., Gebregiworgis, T., Dai, B., Augustine, J. J., Murthy, D., Attri, K. S., Mashadova, O., Grandgenett, P. M., Powers, R., Ly, Q. P. & 17 others, Lazenby, A. J., Grem, J. L., Yu, F., Matés, J. M., Asara, J. M., Kim, J. W., Hankins, J. H., Weekes, C., Hollingsworth, M. A., Serkova, N. J., Sasson, A. R., Fleming, J. B., Oliveto, J. M., Lyssiotis, C. A., Cantley, L. C., Berim, L. & Singh, P., Sep 11 2017, In : Cancer Cell. 32, 3, 1 p.

Research output: Contribution to journalComment/debate

15 Scopus citations

Extent of resection in glioblastoma

Shonka, N. A. & Aizenberg, M. R., Oct 2017, In : Journal of oncology practice. 13, 10, p. 641-642 2 p.

Research output: Contribution to journalComment/debate

2 Scopus citations

Haematological cancer: Staging and restaging patients with lymphoma-a better approach?

Bhatt, V. R. & Armitage, J. O., Sep 1 2017, In : Nature Reviews Clinical Oncology. 14, 9, p. 527-528 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Identifying patients with leukemia who are at risk for fungal infections

Bhatt, V. R., Jul 2017, In : Clinical Advances in Hematology and Oncology. 15, 7, p. 518-520 3 p.

Research output: Contribution to journalComment/debate

Progress in TP53-deficient chronic lymphocytic leukemia: More questions than answers

Bociek, R. G., Jun 1 2017, In : Journal of oncology practice. 13, 6, p. 379-380 2 p.

Research output: Contribution to journalComment/debate

2016

Anaplastic thyroid carcinoma: Light at the end of the tunnel?

Ganti, A. K., Jun 2016, In : Journal of oncology practice. 12, 6, p. 519-520 2 p.

Research output: Contribution to journalComment/debate

Evolution of low-grade glioma therapy

Aizenberg, M. R., Dec 1 2016, In : Journal of oncology practice. 12, 12, p. 1242-1243 2 p.

Research output: Contribution to journalComment/debate

How do we best ensure that rosebuds are gathered?

Reed, E., Nov 1 2016, In : Journal of oncology practice. 12, 11, p. 1157-1159 3 p.

Research output: Contribution to journalComment/debate

Improved survival with salvage autologous stem-cell transplantation in myeloma

Holstein, S. A. & McCarthy, P. L., Jul 1 2016, In : The Lancet Haematology. 3, 7, p. e306-e307

Research output: Contribution to journalComment/debate

Searching for synergy: Combining drugs and stereotactic radiosurgery for the treatment of brain metastases

Shonka, N. A. & Zhang, C., Aug 2016, In : Journal of oncology practice. 12, 8, p. 713-714 2 p.

Research output: Contribution to journalComment/debate

2015

An interview with Julie Vose: Where is oncology heading?

Vose, J. M., Oct 2015, In : Future Oncology. 11, 20, p. 2803-2805 3 p.

Research output: Contribution to journalComment/debate

Continued role for ASCT in multiple myeloma

McCarthy, P. L. & Holstein, S. A., 2015, In : The Lancet Oncology. 16, 16, p. 1571-1573 3 p.

Research output: Contribution to journalComment/debate

Erratum: MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway (Oncogene (2015) 34:2814 DOI:10.1038/onc.2015.116)

Macha, M. A., Rachagani, S., Pai, P., Gupta, S., Lydiatt, W. M., Smith, R. B., Johansson, S. L., Lele, S. M., Kakar, S. S., Farghaly, H., Lee, J. H., Meza, J., Ganti, A. K., Jain, M. & Batra, S. K., May 21 2015, In : Oncogene. 34, 21, 1 p.

Research output: Contribution to journalComment/debate

2014

Commentary: Diagnostic dilemmas that impact treatment decisions in lymphoma

Vose, J. M., Jan 1 2014, In : Clinical Advances in Hematology and Oncology. 12, 1, p. 12-13 2 p.

Research output: Contribution to journalComment/debate

Erratum: NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors (Evidence-based Complementary and Alternative Medicine)

Mansky, P. J., Wallerstedt, D. B., Sannes, T. S., Stagl, J., Johnson, L. L., Blackman, M. R., Grem, J. L., Swain, S. M. & Monahan, B. P., 2014, In : Evidence-based Complementary and Alternative Medicine. 2014, 606348.

Research output: Contribution to journalComment/debate

2 Scopus citations

Erratum: Should patients with aggressive peripheral t-cell lymphoma all be treated the same? (The Cancer Journal (2012) 18 (445-449))

Moskowitz, A. J., Lunning, M. A. & Horwitz, S. M., 2014, In : Cancer Journal (United States). 20, 2, 1 p.

Research output: Contribution to journalComment/debate

Safety and efficacy of preoperative sorafenib therapy in facilitating cytoreductive surgery in renal cell carcinoma

Bhatt, V. R., Ganti, A. K., Schwarz, J. K. & Wang, J., Apr 2014, In : Future Oncology. 10, 5, p. 703-706 4 p.

Research output: Contribution to journalComment/debate

3 Scopus citations

Sorafenib in squamous cell carcinoma of the head and neck: Molecular basis and potential role

Bhatt, V. R. & Ganti, A. K., Jan 1 2014, In : Future Oncology. 10, 1, p. 17-20 4 p.

Research output: Contribution to journalComment/debate

2 Scopus citations

Targeted therapy in metastatic colon cancer

Bhatt, V. R., Apr 2014, In : Future Oncology. 10, 5, p. 707-711 5 p.

Research output: Contribution to journalComment/debate

2 Scopus citations
2013

Brentuximab vedotin: The science of common sense

Lunning, M. A. & Younes, A., Oct 2013, In : Leukemia and Lymphoma. 54, 10, p. 2089-2090 2 p.

Research output: Contribution to journalComment/debate

Erratum to "Management of squamous cell carcinoma of the head and neck in the elderly: Review and recommendations" [J. Geriatr. Oncol. 3 (2012) 265-272]

Weir, A., Ganti, A. K., deShazo, M., Samant, S. & Hurria, A., Jan 2013, In : Journal of Geriatric Oncology. 4, 1, 1 p.

Research output: Contribution to journalComment/debate

Rash and ear swelling in a patient with febrile neutropenia

Berg, I., Nenninger, T., DiMaio, D., Bierman, P. & Sandkovsky, U., May 2013, In : International Journal of Infectious Diseases. 17, 5, p. e360-e361

Research output: Contribution to journalComment/debate

1 Scopus citations

Ten years of progress in the treatment of Non-Hodgkin's Lymphoma

Vose, J. M., Jan 1 2013, In : JNCCN Journal of the National Comprehensive Cancer Network. 11, 1, p. 3-4 2 p.

Research output: Contribution to journalComment/debate

2012

Erratum: A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma (Cancer DOI: 10.1002/cncr.26510)

Cheson, B. D., Bartlett, N. L., Vose, J. M., Lopez-Hernandez, A., Seiz, A. L., Keating, A. T., Shamsili, S., Papadopoulos, K. P. & Papadopoulos, K. P., Sep 1 2012, In : Cancer. 118, 17, 1 p.

Research output: Contribution to journalComment/debate

Sarcoidosis mimicking recurrent lymphoma

Li, W., Holdeman, K., Laurini, J. A., Bierman, P. J., Vose, J. M., Bociek, R. G. & Armitage, J. O., Jul 2012, In : American Journal of Hematology. 87, 7, p. 711-712 2 p.

Research output: Contribution to journalComment/debate

5 Scopus citations

Splenic marginal zone lymphoma: villous, not necessarily villainous.

Bociek, R. G., Feb 2012, In : Oncology (Williston Park, N.Y.). 26, 2, p. 208, 210

Research output: Contribution to journalComment/debate

Transplantation for Lymphoma: Good for the Brain asWell as the Body?

Bierman, P. J. & Armitage, J. O., Jan 2012, In : Biology of Blood and Marrow Transplantation. 18, 1, p. 1-2 2 p.

Research output: Contribution to journalComment/debate

2011

Bioluminescence in drug development for cancer: Shedding light on therapeutic efficacy

Talmadge, J. E., May 1 2011, In : Cancer Biology and Therapy. 11, 9, p. 846-848 3 p.

Research output: Contribution to journalComment/debate

3 Scopus citations

Erratum: Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro (Leukemia (2011) 25 (348-358) DOI:10.1038/leu.2010.255)

Iqbal, J., Weisenburger, D. D., Chowdhury, A., Tsai, M. Y., Srivastava, G., Greiner, T. C., Kucuk, C., Deffenbacher, K., Vose, J., Smith, L., Au, W. Y., Nakamura, S., Seto, M., Delabie, J., Berger, F., Loong, F., Ko, Y. H., Sng, I., Liu, X., Loughran, T. P. & 2 others, Armitage, J. & Chan, W. C., Aug 2011, In : Leukemia. 25, 8, 1 p.

Research output: Contribution to journalComment/debate

3 Scopus citations

Intensified chemotherapy for diffuse large B-cell lymphomas

Vose, J. M., Nov 26 2011, In : The Lancet. 378, 9806, p. 1828-1829 2 p.

Research output: Contribution to journalComment/debate

3 Scopus citations

PET scans: When and how?

Armitage, J. O., Jul 7 2011, In : Blood. 118, 1, p. 2-3 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Retrospective on the last quarter-century in hematologic oncology

Armitage, J. O., May 2011, In : ONCOLOGY. 25, 5

Research output: Contribution to journalComment/debate

2009

Another nail in the coffin for hormone-replacement therapy?

Ganti, A. K., 2009, In : The Lancet. 374, 9697, p. 1217-1218 2 p.

Research output: Contribution to journalComment/debate

6 Scopus citations

Cancer care - The relation between resources and outcome

Armitage, J. O., 2009, In : Leukemia and Lymphoma. 50, 2, p. 152-153 2 p.

Research output: Contribution to journalComment/debate

Erratum: Gum hypertrophy (CMAJ (2009) 180 (471) 10.1503/cmaj.090646)

Gundabolu K, K., Kong, G. & Verma, A., Apr 28 2009, In : CMAJ. Canadian Medical Association Journal. 180, 9, 1 p.

Research output: Contribution to journalComment/debate

Gum hypertrophy

Gundabolu, K., Kong, G. & Verma, A., Feb 17 2009, In : CMAJ. 180, 4, 1 p.

Research output: Contribution to journalComment/debate

3 Scopus citations

Looking back (and ahead) at salvage treatment for non-hodgkin lymphoma

Bierman, P. J. & Armitage, J. O., Jun 2009, In : ONCOLOGY. 23, 7, p. 619+625

Research output: Contribution to journalComment/debate

3 Scopus citations
2008

Follistatin as an inhibitor of experimental metastasis

Talmadge, J. E., Feb 1 2008, In : Clinical Cancer Research. 14, 3, p. 624-626 3 p.

Research output: Contribution to journalComment/debate

5 Scopus citations